arrow
M

Marcy E. Richardson

ambry genetics
H指数:19
被引数:1,697

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An integrated, scaled approach to resolve TSC2 variants of uncertain significance

一种集成且成比例的方法用于解决TSC2意义不明的变异

2026-07-090
OAAI
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification

结合变异效应的多重检测方法以增强BRCA2变异分类

2026-04-090
OAAI
Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk

位点饱和度功能筛选确定与乳腺癌风险增加相关的PALB2错义变异

2026-01-190
OAAI
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes

BRCA1-、BRCA2-和PALB2相关的范可尼贫血:扩展疾病表型特征并预测杂合子乳腺癌风险的潜力

2025-10-300
PRE
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants

ACMG/AMP变异整理指南中关于体细胞PALB2序列变异分析的规定

2025-09-170
OAAI
Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC (Hereditary Leiomyomatosis and Renal Cell Cancer) and renal cancer

量化综合征表型(PP4)特异性证据:大规模整合来自HLRCC(遗传性平滑肌瘤病和肾细胞癌)及肾癌诊断实验室检测的罕见生殖系FH变异

2025-09-040
OAAI
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

ACMG/AMP对BRCA1错义变异的解释:结构信息评分增加了PP3/BP4计算证据的证据强度粒度

2025-05-010
OAAI
Integration of protein stability and AlphaMissense scores improves bioinformatic impact prediction for p53 missense and in-frame amino acid deletion variants

整合蛋白质稳定性与AlphaMissense评分可提高对p53错义突变和框内氨基酸缺失变异的生物信息学影响预测

2025-05-010
PRE
Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS
2024-11-012
OAAI
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants

用于分析种系ATM序列变体的ACMG/AMP变体管理指南的规范

2024-11-010
OAAI
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
2024-09-0112
OAAI